NCT04571112View on ClinicalTrials.gov

GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

October 1, 2020

Study Completion Date

March 1, 2021

Conditions
Parkinson DiseaseMemory Disorders
Interventions
DEVICE

NBM stimulation using the Vercise device (Boston Scientific, Marlborough, Massachusetts, US)

This will either be turned on or off depending on the arm which the patient is randomized to. After 8-weeks, the subject will switch arms for another 8-weeks.

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University of Toronto

OTHER

NCT04571112 - GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter